Importantly, cellular senescence is a hallmark of T2DM, driven primarily by hyperglycemia and contributing to both compromised cellular responsiveness to insulin signaling and inadequate insulin production by pancreatic β-cells [8,9]. The gene discussed is INS; the disease is Hyperglycemia.